These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12517535)

  • 1. Childhood nasopharyngeal carcinoma: from biology to treatment.
    Ayan I; Kaytan E; Ayan N
    Lancet Oncol; 2003 Jan; 4(1):13-21. PubMed ID: 12517535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasopharyngeal carcinoma. Biology, natural history, and therapeutic implications.
    Cvitkovic E; Bachouchi M; Armand JP
    Hematol Oncol Clin North Am; 1991 Aug; 5(4):821-38. PubMed ID: 1890068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology and treatment of nasopharyngeal cancer.
    Fandi A; Cvitkovic E
    Curr Opin Oncol; 1995 May; 7(3):255-63. PubMed ID: 7654828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study.
    Geara FB; Glisson BS; Sanguineti G; Tucker SL; Garden AS; Ang KK; Lippman SM; Clayman GL; Goepfert H; Peters LJ; Hong WK
    Cancer; 1997 Apr; 79(7):1279-86. PubMed ID: 9083147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasopharyngeal carcinoma.
    Brennan B
    Orphanet J Rare Dis; 2006 Jun; 1():23. PubMed ID: 16800883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
    Chua DT; Wei WI; Sham JS; Cheng AC; Au G
    Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects.
    Altun M; Fandi A; Dupuis O; Cvitkovic E; Krajina Z; Eschwege F
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):859-77. PubMed ID: 7790274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcome of childhood nasopharyngeal carcinoma: A single institution experience.
    Nikitovic M; Popovic-Vukovic M; Stanic D; Bokun J; Paripovic L; Ilic V; Miskovic I; Saric M
    Int J Pediatr Otorhinolaryngol; 2018 Oct; 113():168-172. PubMed ID: 30173978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasopharyngeal carcinoma.
    Wei WI; Sham JS
    Lancet; 2005 Jun 11-17; 365(9476):2041-54. PubMed ID: 15950718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of nasopharyngeal carcinoma.
    Jeyakumar A; Brickman TM; Jeyakumar A; Doerr T
    Ear Nose Throat J; 2006 Mar; 85(3):168-70, 172-3, 184. PubMed ID: 16615599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative study of long-term effects between induction chemotherapy and concurrent chemotherapy on patients with local advanced nasopharyngeal carcinoma].
    Wang HB; Chen Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):361-365. PubMed ID: 29871262
    [No Abstract]   [Full Text] [Related]  

  • 12. Nasopharyngeal carcinoma in children: retrospective review of 50 patients.
    Ayan I; Altun M
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):485-92. PubMed ID: 8655371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: Radiotherapy dose adaptation after chemotherapy response to minimize late effects.
    Orbach D; Brisse H; Helfre S; Klijanienko J; Bours D; Mosseri V; Rodriguez J
    Pediatr Blood Cancer; 2008 Apr; 50(4):849-53. PubMed ID: 17973328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasopharyngeal carcinomas: an update.
    Spano JP; Busson P; Atlan D; Bourhis J; Pignon JP; Esteban C; Armand JP
    Eur J Cancer; 2003 Oct; 39(15):2121-35. PubMed ID: 14522369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal management of nasopharyngeal carcinoma.
    Faivre S; Janot F; Armand JP
    Curr Opin Oncol; 2004 May; 16(3):231-5. PubMed ID: 15069318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of rare periparotid recurrence after parotid gland-sparing intensity-modulated radiotherapy for nasopharyngeal carcinoma.
    Xu Y; Zhang M; Yue Q; Zong J; Lin J; Sun R; Qiu S; Lin S; Pan J
    Cancer Radiother; 2016 Jul; 20(5):377-83. PubMed ID: 27372558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic area.
    Huang PY; Zeng Q; Cao KJ; Guo X; Guo L; Mo HY; Wu PH; Qian CN; Mai HQ; Hong MH
    Eur J Cancer; 2015 Sep; 51(13):1760-70. PubMed ID: 26093812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy plus conventional radiotherapy or accelerated hyperfractionation in stage III and IV nasopharyngeal carcinoma--a phase II study.
    El-Weshi A; Khafaga Y; Allam A; Mosseri V; Ibrahim E; El-Serafi M; El-Badawi S
    Acta Oncol; 2001; 40(5):574-81. PubMed ID: 11669328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Undifferentiated carcinoma of nasopharyngeal type in children: Clinical features and outcome.
    Zrafi WS; Tebra S; Tbessi S; Ouni S; Jebsi M; Bouaouina N
    Eur Ann Otorhinolaryngol Head Neck Dis; 2017 Oct; 134(5):321-324. PubMed ID: 28395961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent Chemoradiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma: Treatment Outcomes and Prognostic Factors.
    Kong M; Lim YJ; Kim Y
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1591-1599. PubMed ID: 29936784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.